We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Generic Tablets/Capsules Should Mimic Brand Counterpart
FDA Says Generic Tablets/Capsules Should Mimic Brand Counterpart
Generics makers should design tablets and capsules to be similar in size and shape to their reference listed drug (RLD) when they seek ANDA approval, the FDA says.